HCM
AGN

HM Capital Management’s Allergan plc AGN Stock Holding History

HM Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,552
Closed -$806K – 38
2020
Q1 		$806K Hold
4,552
– – 0.59% 18
2019
Q4 		$870K Hold
4,552
– – 0.52% 21
2019
Q3 		$766K Hold
4,552
– – 0.48% 20
2019
Q2 		$762K Buy
+4,552
New +$630K 0.47% 23

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

HM Capital Management's AGN Position: Q2 2020 in Review

HM Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,552 shares — an estimated $806K sold.

HM Capital Management first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $870K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • HM Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • HM Capital Management sold 4,552 Allergan plc shares in Q2 2020, an estimated $806K.
  • HM Capital Management first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • HM Capital Management's Allergan plc position peaked at $870K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on HM Capital Management's 13F filing for Q2 2020, filed 23 Jul 2020.